Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial

Peuker, Caroline A.; Yaghobramzi, Sarvenaz; Grunert, Corinna; Keilholz, Luisa; Gjerga, Enio; Hennig, Steffen; Schaper, Sigrid; Na, Il-Kang; Keller, Ulrich; Brucker, Sara; Decker, Thomas; Fasching, Peter; Fehm, Tanja; Janni, Wolfgang; Kuemmel, Sherko; Schneeweiss, Andreas; Schuler, Martin; Lueftner, Diana; Busse, Antonia

dc.contributor.author	Brucker, Sara
dc.date.accessioned	2023-05-30T08:38:50Z
dc.date.available	2023-05-30T08:38:50Z
dc.date.issued	2022
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/141489
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2021.11.025	de_DE
dc.subject.ddc	610	de_DE
dc.title	Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_02215
utue.publikation.seiten	45-55	de_DE
utue.personen.roh	Peuker, Caroline A.
utue.personen.roh	Yaghobramzi, Sarvenaz
utue.personen.roh	Grunert, Corinna
utue.personen.roh	Keilholz, Luisa
utue.personen.roh	Gjerga, Enio
utue.personen.roh	Hennig, Steffen
utue.personen.roh	Schaper, Sigrid
utue.personen.roh	Na, Il-Kang
utue.personen.roh	Keller, Ulrich
utue.personen.roh	Brucker, Sara
utue.personen.roh	Decker, Thomas
utue.personen.roh	Fasching, Peter
utue.personen.roh	Fehm, Tanja
utue.personen.roh	Janni, Wolfgang
utue.personen.roh	Kuemmel, Sherko
utue.personen.roh	Schneeweiss, Andreas
utue.personen.roh	Schuler, Martin
utue.personen.roh	Lueftner, Diana
utue.personen.roh	Busse, Antonia
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	162	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE